A Comparison Between Two Formulations of NN5401 in Healthy Subjects
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of the trial is to
compare the exposure of two formulations of insulin degludec/insulin aspart (NN5401) in
healthy subjects.